Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0; this appears to be a minor maintenance/feature update with no changes to study content or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-03-21T19:39:55.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T09:58:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added the disease tag Gastric cancer and a Resources link to the Genetic and Rare Diseases Information Center. Updated page revision from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-14T00:57:57.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T15:21:17.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Minor UI text and label changes were made, including the addition of glossary toggle options and small wording/case updates (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-23T10:16:28.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; this update does not change the study content, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T05:56:34.000Z thumbnail image

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.